ArticleFrontiers in medicine2026
Clinical application of ozone hydrotherapy combined with scalp complex acid treatment for moderate to severe scalp seborrheic dermatitis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study evaluates the effectiveness of combining ozone hydrotherapy with scalp complex acid in treating scalp seborrheic dermatitis (SSD). Methods: A total of 96 patients with moderate to severe SSD were randomly assigned to either the Control group (treated with scalp complex acid) or the Observation group (treated with a combination of ozone hydrotherapy and scalp complex acid). The treatment period lasted 4 weeks. SSD severity was evaluated using a 16-point composite score that assessed erythema, scaling, and pruritus. Total skin damage score was rated on a 4-point scale. Scalp sebum levels were measured using a Sebumeter SM 810, and serum levels of IL-1β and TNF-α were quantified using enzyme-linked immunosorbent assay. Results: After 4 weeks, the Observation group showed significantly greater improvement in erythema, scaling, pruritus, sebum production, and lesion area compared to the Control group. The complete lesion clearance rate was significantly higher in the Observation group (35.6%) than in the Control group (11.6%, Discussion: The combination of ozone hydrotherapy and scalp complex acid showed enhanced therapeutic benefits for SSD, leading to improved clinical outcomes and a reduction in systemic inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.